Skip to main navigation Skip to search Skip to main content

Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

  • Han Sang Kim
  • , Hyeong Ju Kwon
  • , Inkyung Jung
  • , Mi Ran Yun
  • , Myung Ju Ahn
  • , Byung Woog Kang
  • , Jong Mu Sun
  • , Sung Bae Kim
  • , Dok Hyun Yoon
  • , Keon Uk Park
  • , Se Hoon Lee
  • , Yoon Woo Koh
  • , Se Hun Kim
  • , Eun Chang Choi
  • , Dong Hoe Koo
  • , Jin Hee Sohn
  • , Bomi Kim
  • , Nak Jung Kwon
  • , Hwan Jung Yun
  • , Min Goo Lee
    • Ji Hyun Lee, Tae Min Kim, Hye Ryun Kim, Joo Hang Kim, Soonmyung Paik, Byoung Chul Cho

Research output: Contribution to journal › Article › peer-review

56 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science